Livia Biancone

Corrigendum to "Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology" [Digestive and Liver Disease 58 (2026) 1051-1060].

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: August 30, 2026

Dyspareunia and heavy menstrual bleeding as clinical predictors of concomitant endometriosis in Inflammatory Bowel Disease: A multidisciplinary prospective study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: March 24, 2026

Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: January 19, 2026

Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: January 19, 2026

The efficacy and safety of upadacitinib in the treatment of paradoxical amicrobial pustulosis and alopecia induced by infliximab in a patient with Crohn disease.

Journal: JAAD case reports

Published: December 25, 2025

Corrigendum to "Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology" [Digestive and Liver Disease 58 (2026) 1051-1060].

Corrigendum to "Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology" [Digestive and Liver Disease 58 (2026) 1051-1060].

Dyspareunia and heavy menstrual bleeding as clinical predictors of concomitant endometriosis in Inflammatory Bowel Disease: A multidisciplinary prospective study.

Dyspareunia and heavy menstrual bleeding as clinical predictors of concomitant endometriosis in Inflammatory Bowel Disease: A multidisciplinary prospective study.

Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology.

Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology.

Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology.

Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology.

The efficacy and safety of upadacitinib in the treatment of paradoxical amicrobial pustulosis and alopecia induced by infliximab in a patient with Crohn disease.

The efficacy and safety of upadacitinib in the treatment of paradoxical amicrobial pustulosis and alopecia induced by infliximab in a patient with Crohn disease.

Frequency of dysplasia in endoscopically resected pseudopolyps in inflammatory bowel diseases.

Frequency of dysplasia in endoscopically resected pseudopolyps in inflammatory bowel diseases.

Rafoxanide disrupts mitochondrial homeostasis through VDAC1 modulation in colorectal cancer cells.

Rafoxanide disrupts mitochondrial homeostasis through VDAC1 modulation in colorectal cancer cells.

Clinical outcome after entero-enteric anastomosis for Crohn's disease: a case-control study.

Clinical outcome after entero-enteric anastomosis for Crohn's disease: a case-control study.

Inflammatory Bowel Disease Patients with a History of Cancer: Safety of Immunomodulators in a Multicenter Study.

Inflammatory Bowel Disease Patients with a History of Cancer: Safety of Immunomodulators in a Multicenter Study.

Repurposing Rafoxanide: From Parasite Killer to Cancer Fighter.

Repurposing Rafoxanide: From Parasite Killer to Cancer Fighter.

Colitis-Associated Dysplasia in Inflammatory Bowel Disease: Features and Endoscopic Management.

Colitis-Associated Dysplasia in Inflammatory Bowel Disease: Features and Endoscopic Management.

Efficacy and Safety of Janus Kinase-Inhibitors in Ulcerative Colitis.

Efficacy and Safety of Janus Kinase-Inhibitors in Ulcerative Colitis.